Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2006 6
2007 5
2008 2
2009 7
2010 5
2011 8
2012 7
2013 11
2014 17
2015 17
2016 15
2017 29
2018 33
2019 28
2020 15
Text availability
Article attribute
Article type
Publication date

Search Results

177 results
Results by year
Filters applied: . Clear all
Page 1
Antioxidant Properties of Probiotic Bacteria.
Wang Y, Wu Y, Wang Y, Xu H, Mei X, Yu D, Wang Y, Li W. Wang Y, et al. Among authors: Wu Y. Nutrients. 2017 May 19;9(5):521. doi: 10.3390/nu9050521. Nutrients. 2017. PMID: 28534820 Free PMC article. Review.
Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma.
Bleecker ER, Wechsler ME, FitzGerald JM, Menzies-Gow A, Wu Y, Hirsch I, Goldman M, Newbold P, Zangrilli JG. Bleecker ER, et al. Among authors: Wu Y. Eur Respir J. 2018 Oct 18;52(4):1800936. doi: 10.1183/13993003.00936-2018. Print 2018 Oct. Eur Respir J. 2018. PMID: 30139780 Free PMC article. Clinical Trial.
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia.
Laviolette M, Gossage DL, Gauvreau G, Leigh R, Olivenstein R, Katial R, Busse WW, Wenzel S, Wu Y, Datta V, Kolbeck R, Molfino NA. Laviolette M, et al. Among authors: Wu Y. J Allergy Clin Immunol. 2013 Nov;132(5):1086-1096.e5. doi: 10.1016/j.jaci.2013.05.020. Epub 2013 Jul 16. J Allergy Clin Immunol. 2013. PMID: 23866823 Free PMC article. Clinical Trial.
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Ferguson GT, FitzGerald JM, Bleecker ER, Laviolette M, Bernstein D, LaForce C, Mansfield L, Barker P, Wu Y, Jison M, Goldman M; BISE Study Investigators. Ferguson GT, et al. Among authors: Wu Y. Lancet Respir Med. 2017 Jul;5(7):568-576. doi: 10.1016/S2213-2600(17)30190-X. Epub 2017 May 22. Lancet Respir Med. 2017. PMID: 28545978 Clinical Trial.
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.
Castro M, Wenzel SE, Bleecker ER, Pizzichini E, Kuna P, Busse WW, Gossage DL, Ward CK, Wu Y, Wang B, Khatry DB, van der Merwe R, Kolbeck R, Molfino NA, Raible DG. Castro M, et al. Among authors: Wu Y. Lancet Respir Med. 2014 Nov;2(11):879-890. doi: 10.1016/S2213-2600(14)70201-2. Epub 2014 Oct 8. Lancet Respir Med. 2014. PMID: 25306557 Clinical Trial.
Effects of puerarin on the pharmacokinetics of triptolide in rats.
Wang Q, Wu Y, Xiang F, Feng Y, Li Z, Ding Y. Wang Q, et al. Among authors: Wu Y. Pharm Biol. 2019 Dec;57(1):407-411. doi: 10.1080/13880209.2019.1626448. Pharm Biol. 2019. PMID: 31230510 Free PMC article.
The role of autophagy in maintaining intestinal mucosal barrier.
Wu Y, Tang L, Wang B, Sun Q, Zhao P, Li W. Wu Y, et al. J Cell Physiol. 2019 Nov;234(11):19406-19419. doi: 10.1002/jcp.28722. Epub 2019 Apr 24. J Cell Physiol. 2019. PMID: 31020664 Review.
MTOR Suppresses Environmental Particle-Induced Inflammatory Response in Macrophages.
Li Z, Wu Y, Chen HP, Zhu C, Dong L, Wang Y, Liu H, Xu X, Zhou J, Wu Y, Li W, Ying S, Shen H, Chen ZH. Li Z, et al. Among authors: Wu Y, Wu Y. J Immunol. 2018 Apr 15;200(8):2826-2834. doi: 10.4049/jimmunol.1701471. Epub 2018 Mar 21. J Immunol. 2018. PMID: 29563176 Free article.
177 results
Jump to page